ZYDUS LIFESCIENCES
Back to Cashflow Statement
|
ZYDUS LIFESCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹3,228 Cr | ₹2,689 Cr | ₹2,105 Cr | ₹3,294 Cr | ₹2,932 Cr |
What is the latest Cash Flow from Operating Activities ratio of ZYDUS LIFESCIENCES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹3,228 Cr |
Mar2023 | ₹2,689 Cr |
Mar2022 | ₹2,105 Cr |
Mar2021 | ₹3,294 Cr |
Mar2020 | ₹2,932 Cr |
How is Cash Flow from Operating Activities of ZYDUS LIFESCIENCES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹3,228 Cr | 20.05 | |
Mar2023 | ₹2,689 Cr | 27.76 | |
Mar2022 | ₹2,105 Cr | -36.11 | |
Mar2021 | ₹3,294 Cr | 12.36 | |
Mar2020 | ₹2,932 Cr | - |
Compare Cash Flow from Operating Activities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹95,010.4 Cr | -2% | -6.1% | 49.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹426,518.0 Cr | -0.1% | -6.3% | 49.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,636.0 Cr | 3.5% | 0.9% | 66.2% | Stock Analytics | |
CIPLA | ₹118,368.0 Cr | -2.6% | -3.8% | 19.2% | Stock Analytics | |
MANKIND PHARMA | ₹102,273.0 Cr | 0.9% | -3.4% | 37% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,671.4 Cr | -4.1% | -10.8% | 9.5% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -2% |
-6.1% |
49.9% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses